New antibiotic tackles drug-resistant gonorrhea in trial
The first new antibiotic for gonorrhea—the second most common sexually transmitted disease—has shown promise in a clinical trial.
Nov 3, 2023
0
156
MeSH tree: D02.540.576.500.992
The first new antibiotic for gonorrhea—the second most common sexually transmitted disease—has shown promise in a clinical trial.
Nov 3, 2023
0
156
A new study published today in the American Journal of Infection Control (AJIC) reveals that the use of doxycycline may help protect against Clostridioides difficile (C. diff) infection for some patients with pneumonia.
Nov 2, 2023
0
76
An easily implemented genome-sequencing method could help public health officials combat America's ongoing syphilis epidemic, researchers at the University of Washington School of Medicine and Public Health-Seattle & King ...
Sep 28, 2023
0
40
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, in collaboration with Nanyang ...
Jun 6, 2023
0
40
French medical bodies on Sunday called on authorities to punish researcher Didier Raoult for "the largest 'unauthorized' clinical trial ever seen" into the use of hydroxychloroquine to treat COVID-19.
May 28, 2023
0
67
A three-year-old girl contracted an unusual Mycobacterium marinum infection that developed following an iguana bite while she was on holiday in Costa Rica. The doctors who treated her will report on the case at this year's ...
Mar 31, 2023
0
143
Three weeks of oral azithromycin seems to be equivalent to six weeks of doxycycline for treatment of severe meibomian gland dysfunction (MGD), according to a study published online March 23 in JAMA Ophthalmology.
Mar 31, 2023
0
72
Pneumococcal disease leads to over three million hospitalizations and hundreds of thousands of deaths annually. A study publishing March 16th in the open access journal PLOS Biology by Carlos J. Orihuela at the University ...
Mar 16, 2023
0
74
A large LSTM-led trial confirms new antimalarial, dihydroartemisinin-piperaquine, is more effective at preventing malaria than current WHO recommended treatment but does not improve adverse birth outcomes.
Mar 13, 2023
0
72
A single oral dose of the antibiotic azithromycin can reduce the risk of postpartum sepsis and death among women who deliver vaginally by one-third, according to a large multi-country clinical trial, called A-PLUS. Only 1.6% ...
Feb 9, 2023
0
116